#cdmo — Public Fediverse posts

Vetter Starts Construction of a New Production Site in Germany

© Vetter Pharma International GmbH: Representatives of the pharmaceutical service provider Vetter, the economic development agency gwSaar, and…
#Germany #DE #Europe #EU #Europa #AnkeRehlinger #CDMO #groundbreakingceremony #ManufacturingOrganization #NicholasH.Vetter #RAVENSBURG #Saarlouis #UdoJ.Vetter #Vetter
https://www.europesays.com/germany/13428/

ESTEVE’S EXPANSION AND GROWTH IN EU AND USA ACCELERATES ITS TRANSFORMATION INTO A GLOBAL HEALTHCARE COMPANY

New assets in both businesses – Pharma and CDMO – fuel double-digit growth in net revenues and EBITDA…
#Europe #EU #CDMO #developmentcapabilities #ESTEVE #EuropeanUnion #globalhealthcarecompany #growthstrategy #inorganicgrowth #strategyexecution
https://www.europesays.com/europe/30951/

Evonik: €80m for biopharma CDMO capacity in Slovakia

The speciality chemicals group Evonik is driving its strategic transformation forward and is selectively expanding its biotechnology business.…
#Slovakia #SK #Europe #Europa #EU #CDMO #Evonik #investment #slovakia #Slovensko #Správy
https://www.europesays.com/2948636/

Evonik: €80m for biopharma CDMO capacity in Slovakia

The speciality chemicals group Evonik is driving its strategic transformation forward and is selectively expanding its biotechnology business.…
#Europe #EU #CDMO #European #Evonik #Investment #Slovakia
https://www.europesays.com/europe/23742/

Evonik: €80m for biopharma CDMO capacity in Slovakia https://www.byteseu.com/1968612/ #CDMO #Evonik #investment #Slovakia

If the two sides continue to fail to reach an agreement, the union will begin collective action on May 21, followed by a full general strike on May 1, ...

Samsung Biologics faces its first strike since founding as 95.5% of union voters back walkout, threatening the company's 15 trillion won CDMO expansion strategy amid global competition.#SamsungBiologics #strike #laborunion #CDMO #biopharmaceutical #collectivebargaining #wagenegotiation #SamsungGroup
Samsung Biologics Faces First Strike in 15-Year History

If the two sides continue to fail to reach an agreement, the union will begin collective action on May 21, followed by a full general strike on May 1, ...

Samsung Biologics faces its first strike since founding as 95.5% of union voters back walkout, threatening the company's 15 trillion won CDMO expansion strategy amid global competition.#SamsungBiologics #strike #laborunion #CDMO #biopharmaceutical #collectivebargaining #wagenegotiation #SamsungGroup
Samsung Biologics Faces First Strike in 15-Year History

If the two sides continue to fail to reach an agreement, the union will begin collective action on May 21, followed by a full general strike on May 1, ...

Samsung Biologics faces its first strike since founding as 95.5% of union voters back walkout, threatening the company's 15 trillion won CDMO expansion strategy amid global competition.#SamsungBiologics #strike #laborunion #CDMO #biopharmaceutical #collectivebargaining #wagenegotiation #SamsungGroup
Samsung Biologics Faces First Strike in 15-Year History

If the two sides continue to fail to reach an agreement, the union will begin collective action on May 21, followed by a full general strike on May 1, ...

Samsung Biologics faces its first strike since founding as 95.5% of union voters back walkout, threatening the company's 15 trillion won CDMO expansion strategy amid global competition.#SamsungBiologics #strike #laborunion #CDMO #biopharmaceutical #collectivebargaining #wagenegotiation #SamsungGroup
Samsung Biologics Faces First Strike in 15-Year History

The union plans, should the vote approve strike action, to begin collective action on May 21 and escalate to a full-scale general strike on May 1, ...

Samsung Biologics faces its first-ever strike as union members overwhelmingly vote on industrial action after 13 rounds of failed wage negotiations, with workers demanding 14% pay raises amid record earnings.#SamsungBiologics #laborstrike #wagenegotiations #CDMO #biopharmaceutical #unionvote #SamsungGroup #collectivebargaining
Samsung Biologics Faces First-Ever Strike as 95% of Union Members Vote

The union plans, should the vote approve strike action, to begin collective action on May 21 and escalate to a full-scale general strike on May 1, ...

Samsung Biologics faces its first-ever strike as union members overwhelmingly vote on industrial action after 13 rounds of failed wage negotiations, with workers demanding 14% pay raises amid record earnings.#SamsungBiologics #laborstrike #wagenegotiations #CDMO #biopharmaceutical #unionvote #SamsungGroup #collectivebargaining
Samsung Biologics Faces First-Ever Strike as 95% of Union Members Vote

The union plans, should the vote approve strike action, to begin collective action on May 21 and escalate to a full-scale general strike on May 1, ...

Samsung Biologics faces its first-ever strike as union members overwhelmingly vote on industrial action after 13 rounds of failed wage negotiations, with workers demanding 14% pay raises amid record earnings.#SamsungBiologics #laborstrike #wagenegotiations #CDMO #biopharmaceutical #unionvote #SamsungGroup #collectivebargaining
Samsung Biologics Faces First-Ever Strike as 95% of Union Members Vote

The union plans, should the vote approve strike action, to begin collective action on May 21 and escalate to a full-scale general strike on May 1, ...

Samsung Biologics faces its first-ever strike as union members overwhelmingly vote on industrial action after 13 rounds of failed wage negotiations, with workers demanding 14% pay raises amid record earnings.#SamsungBiologics #laborstrike #wagenegotiations #CDMO #biopharmaceutical #unionvote #SamsungGroup #collectivebargaining
Samsung Biologics Faces First-Ever Strike as 95% of Union Members Vote

Avethera übernimmt Fraunhofer-GMP in Braunschweig

Es klingt gepflegt umschreibend, was die Ursache für einen Verkauf des Fraunhofer ITEM-Standortes in Braunschweig angeht: „Aufgrund des…
#Braunschweig #Deutschland #Deutsch #DE #Schlagzeilen #Headlines #Nachrichten #News #Europe #Europa #EU #Alvotech #AndreasHerrmann #AvetheraGmbH #Biosimilars #CDMO #Celonic #FahimeMahboudi #FraunhoferGesellschaft(FhG) #Germany #Hennigsdorf #HZI #Leva #Niedersachsen
https://www.europesays.com/de/901104/

Ardena completes divestment of its Södertälje drug substance site in Sweden to Nanologica

Ardena Holding NV. GMP Reactor Operations Reactor systems supporting drug substance manufacturing operations · GlobeNewswire Inc. Ghent, Belgium,…
#Sweden #Sverige #SE #Europe #Europa #EU #Ardena #CDMO #drugproduct #drugsubstance #manufacturingoperations #NanologicaGroup #nyheter #Pharmaceuticalcompanies #Södertälje #sweden
https://www.europesays.com/2740213/

Korea Biomedicine Industry Association Chairman Lee Jeong-seok highlighted 2025 as a year of transition and restructuring for the bio industry, projecting significant growth and global competitiveness in the coming year through advances in AI drug development, biosimilars, and CDMO.
#YonhapInfomax #KoreaBiomedicineIndustryAssociation #Biopharmaceutical #AIDrugDevelopment #Biosimilars #CDMO #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=97657

Korea Biomedicine Industry Association Chairman Lee Jeong-seok highlighted 2025 as a year of transition and restructuring for the bio industry, projecting significant growth and global competitiveness in the coming year through advances in AI drug development, biosimilars, and CDMO.
#YonhapInfomax #KoreaBiomedicineIndustryAssociation #Biopharmaceutical #AIDrugDevelopment #Biosimilars #CDMO #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=97657

Korea Biomedicine Industry Association Chairman Lee Jeong-seok highlighted 2025 as a year of transition and restructuring for the bio industry, projecting significant growth and global competitiveness in the coming year through advances in AI drug development, biosimilars, and CDMO.
#YonhapInfomax #KoreaBiomedicineIndustryAssociation #Biopharmaceutical #AIDrugDevelopment #Biosimilars #CDMO #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=97657

Korea Biomedicine Industry Association Chairman Lee Jeong-seok highlighted 2025 as a year of transition and restructuring for the bio industry, projecting significant growth and global competitiveness in the coming year through advances in AI drug development, biosimilars, and CDMO.
#YonhapInfomax #KoreaBiomedicineIndustryAssociation #Biopharmaceutical #AIDrugDevelopment #Biosimilars #CDMO #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=97657

IDT Biologika, the European subsidiary of SK Bioscience, is ramping up efforts to secure global CDMO contracts by participating in major industry events and leveraging synergies with its parent company.
#YonhapInfomax #SKBioscience #IDTBiologika #CDMO #VaccineMarket #GlobalOrders #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=89250

IDT Biologika, the European subsidiary of SK Bioscience, is ramping up efforts to secure global CDMO contracts by participating in major industry events and leveraging synergies with its parent company.
#YonhapInfomax #SKBioscience #IDTBiologika #CDMO #VaccineMarket #GlobalOrders #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=89250

IDT Biologika, the European subsidiary of SK Bioscience, is ramping up efforts to secure global CDMO contracts by participating in major industry events and leveraging synergies with its parent company.
#YonhapInfomax #SKBioscience #IDTBiologika #CDMO #VaccineMarket #GlobalOrders #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=89250

IDT Biologika, the European subsidiary of SK Bioscience, is ramping up efforts to secure global CDMO contracts by participating in major industry events and leveraging synergies with its parent company.
#YonhapInfomax #SKBioscience #IDTBiologika #CDMO #VaccineMarket #GlobalOrders #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=89250

Lotte Biologics and SK Pharmteco have signed a strategic LOI to jointly provide ADC-specialized CDMO services, aiming to expand their presence in the global antibody-drug conjugate market.
#YonhapInfomax #LotteBiologics #SKPharmteco #ADC #CDMO #GlobalMarket #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=88171

Lotte Group Chairman Shin Dong-bin visited the Lotte Biologics Syracuse Bio Campus in New York to inspect the newly operational ADC facility, urging a focus on expanding global competitiveness and securing additional CDMO contracts as the company ramps up its US bio business.
#YonhapInfomax #LotteBiologics #ADCFacility #ShinDongBin #CDMO #USBioBusiness #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=84877

Lotte Group Chairman Shin Dong-bin visited the Lotte Biologics Syracuse Bio Campus in New York to inspect the newly operational ADC facility, urging a focus on expanding global competitiveness and securing additional CDMO contracts as the company ramps up its US bio business.
#YonhapInfomax #LotteBiologics #ADCFacility #ShinDongBin #CDMO #USBioBusiness #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=84877

Lotte Group Chairman Shin Dong-bin visited the Lotte Biologics Syracuse Bio Campus in New York to inspect the newly operational ADC facility, urging a focus on expanding global competitiveness and securing additional CDMO contracts as the company ramps up its US bio business.
#YonhapInfomax #LotteBiologics #ADCFacility #ShinDongBin #CDMO #USBioBusiness #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=84877

Lotte Group Chairman Shin Dong-bin visited the Lotte Biologics Syracuse Bio Campus in New York to inspect the newly operational ADC facility, urging a focus on expanding global competitiveness and securing additional CDMO contracts as the company ramps up its US bio business.
#YonhapInfomax #LotteBiologics #ADCFacility #ShinDongBin #CDMO #USBioBusiness #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=84877

Amid tariff wars, Canada’s pharma services industry sees opportunity

Key Insights Canadian firms are positioning the country as a hub for pharmaceutical services Some industry insiders…
#NewsBeep #News #Canada #CA #CDMO #drugdevelopment #drugdiscovery #Drugmanufacturing #outsourcing #pharmaceuticals #Tariffs #Trunp #usa
https://www.newsbeep.com/ca/116920/

Evotec veut céder son site de Toulouse à Sandoz

Le site de bioproduction Evotec de Toulouse n’aura battu pavillon allemand que quelques mois. Cette usine, inaugurée…
#Toulouse #FR #France #Actu #News #Europe #EU #actu #Actualités #cdmo #europe #evotec #Haute-Garonne #Occitanie #Pharma #Républiquefrançaise #sandoz #sante-pharma #toulouse
https://www.europesays.com/fr/329156/

https://www.europesays.com/fr/329156/ Evotec veut céder son site de Toulouse à Sandoz #actu #Actualités #cdmo #EU #europe #evotec #FR #France #HauteGaronne #News #Occitanie #Pharma #RépubliqueFrançaise #sandoz #SantePharma #toulouse

JCR Pharmaceuticals Selected for Japan’s Regenerative Medicine CDMO Subsidy Program https://www.byteseu.com/1201573/ #CDMO #FacilityUpgrades #GeneTherapies #GeneticDiseases #Japan #JCR #ManufacturingOrganization #Pharmaceuticals #RareDiseases #RegenerativeMedicine

Lotte Biologics has signed a contract manufacturing agreement with OTTIMO Pharma to produce antibody drug substances at its Syracuse Bio Campus, strengthening its global CDMO presence.
#YonhapInfomax #LotteBiologics #OTTIMOPharma #AntibodyDrug #CDMO #SyracuseBioCampus #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=68343

Lotte Biologics has signed a contract manufacturing agreement with OTTIMO Pharma to produce antibody drug substances at its Syracuse Bio Campus, strengthening its global CDMO presence.
#YonhapInfomax #LotteBiologics #OTTIMOPharma #AntibodyDrug #CDMO #SyracuseBioCampus #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=68343

Lotte Biologics has signed a contract manufacturing agreement with OTTIMO Pharma to produce antibody drug substances at its Syracuse Bio Campus, strengthening its global CDMO presence.
#YonhapInfomax #LotteBiologics #OTTIMOPharma #AntibodyDrug #CDMO #SyracuseBioCampus #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=68343

Lotte Biologics has signed a contract manufacturing agreement with OTTIMO Pharma to produce antibody drug substances at its Syracuse Bio Campus, strengthening its global CDMO presence.
#YonhapInfomax #LotteBiologics #OTTIMOPharma #AntibodyDrug #CDMO #SyracuseBioCampus #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=68343

Lotte Biologics has signed a contract manufacturing agreement with OTTIMO Pharma to produce antibody drug substances at its Syracuse Bio Campus, strengthening its global CDMO presence.
#YonhapInfomax #LotteBiologics #OTTIMOPharma #AntibodyDrug #CDMO #SyracuseBioCampus #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=68343

Samsung Biologics' spin-off announcement sparks debate in securities industry, with some expecting stock price rise due to improved CDMO focus and profitability, while others remain cautious about new entity's valuation.
#YonhapInfomax #SamsungBiologics #SpinOff #CDMO #CorporateValue #StockPriceImpact #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64475

Samsung Biologics announces spin-off to separate CDMO and biosimilar businesses, aiming to resolve conflicts of interest and secure growth momentum in both sectors.
#YonhapInfomax #SamsungBiologics #CDMO #Biosimilars #CorporateRestructuring #BiotechIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64326

Samsung Biologics announces spin-off to resolve CDMO-biosimilar conflicts, aiming to enhance growth potential and investor clarity in both business segments
#YonhapInfomax #SamsungBiologics #CDMO #Biosimilars #CorporateSpinoff #ConflictOfInterest #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64313

🌍 Master the Global API Business!
Enroll in Royed’s 360° Executive Program in API Business Development 💊📈
✅ Licensing | Sourcing | BD Strategy | Regulatory
🔗 https://zurl.co/TbnA4
#API #PharmaBD #RoyedTraining #PharmaIndustry #CDMO #TechTransfer #PharmaBusiness

I'm trying to push for an open-source #ERP and looking for suggestions.Working at a #CDMO, supply chain department. Currently looking at odoo. Boost's appreciated :apartyblob: